APA (7th ed.) Citation

KA, A., ES, A., TM, M., DH, S., MN, S., UN, V., . . . HI, S. (2021). Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. European urology open science, 34, 70. https://doi.org/10.1016/j.euros.2021.09.015

Chicago Style (17th ed.) Citation

KA, Autio, et al. "Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy." European Urology Open Science 34 (2021): 70. https://doi.org/10.1016/j.euros.2021.09.015.

MLA (9th ed.) Citation

KA, Autio, et al. "Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy." European Urology Open Science, vol. 34, 2021, p. 70, https://doi.org/10.1016/j.euros.2021.09.015.